Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Creson ShellieChief Risk Officer | Grant or award | A | — 10.4K sh | Jan 16, 2026 |
| 9 | Kozlowski Daniel RDirector | Grant or award | A | — 2,653 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Porter Jennifer EChief Marketing Officer | Option exercise | M | — 10.0K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller | Grant or award | A | $585 52 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Sanders Dana M.Chief Audit Executive | Grant or award | A | — 1,458 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Gregory Andrew J. Jr.Chief Financial Officer | Grant or award | A | — 5,701 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Earnshaw Timothy JSVP, CAO & Treasurer | Grant or award | A | — 106 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,739 155 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Upshaw Jennifer SpinksChief Administrative Officer | Grant or award | A | — 2,187 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Bishop Daniel ZacharyChief Operating Officer | Grant or award | A | — 2,812 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Creson ShellieChief Risk Officer | Grant or award | A | — 6,560 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Hettrich KevinCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $104K 9,800 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Porter Jennifer EChief Marketing Officer | Tax withholding | F | $39K 3,515 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Tariq MusaDirector | Option exercise | M | — 250 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Sanders Dana M.Chief Audit Executive | Grant or award | A | — 625 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Peil A JosephExecutive VP and CIO | Grant or award | A | — 121 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Jenkins Robert MExecutive VP and COO | Grant or award | A | — 94 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Kuriakose EmilChief Medical Officer | Grant or award | A | — 112.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Mcdonough GeoffDirector | Option exercise | M | — 395 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Bird Justin ChristopherExecutive Vice President | Tax withholding | F | $591 6 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Conway Kevin JohnChief Financial Officer | Tax withholding | F | $95.88 17 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Sumerlin Charissa DChief Credit Officer | Grant or award | A | — 5,102 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Hurley Jill KChief Accounting Officer | Grant or award | A | — 1,302 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Upshaw Jennifer SpinksChief Administrative Officer | Grant or award | A | — 5,102 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 9 | Neils Scott CCFO and Assistant Secretary | Tax withholding | F | $5,255 8,084 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $14K 200 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 8 | Scott JacobGENERAL COUNSEL AND CORP. SEC. | Open-market sale · 10b5-1 plan | SELL | $154K 21.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Blanchard SarahChief Financial Officer | Tax withholding | F | $56K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Jarboe Scott T.CAO and Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $74K 2,151 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $125K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 7 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 321 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 7 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Grant or award · 10b5-1 plan | A | — 44.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 7 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | — 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $126K 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Sumner CrystalSee Remarks | Open-market sale · 10b5-1 plan | SELL | $22K 5,055 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $126K 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Larroque Alexander LisaSVP, Corp Affairs and HR | Tax withholding | F | $923 10 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Sedgwick Karen LExecutive VP and CFO | Tax withholding | F | $568 6 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Wold Dyan Z.VP, Controller and CAO | Tax withholding | F | $487 5 sh | Jan 16, 2026 traded Jan 15, 2026 |